❌

Reading view

LatentPilot: Scene-Aware Vision-and-Language Navigation by Dreaming Ahead with Latent Visual Reasoning

arXiv:2603.29165v1 Announce Type: cross Abstract: Existing vision-and-language navigation (VLN) models primarily reason over past and current visual observations, while largely ignoring the future visual dynamics induced by actions. As a result, they often lack an effective understanding of the causal relationship between actions and how the visual world changes, limiting robust decision-making. Humans, in contrast, can imagine the near future by leveraging action-dynamics causality, which improves both environmental understanding and navigation choices. Inspired by this capability, we propose LatentPilot, a new paradigm that exploits future observations during training as a valuable data source to learn action-conditioned visual dynamics, while requiring no access to future frames at inference. Concretely, we propose a flywheel-style training mechanism that iteratively collects on-policy trajectories and retrains the model to better match the agent's behavior distribution, with an expert takeover triggered when the agent deviates excessively. LatentPilot further learns visual latent tokens without explicit supervision; these latent tokens attend globally in a continuous latent space and are carried across steps, serving as both the current output and the next input, thereby enabling the agent to dream ahead and reason about how actions will affect subsequent observations. Experiments on R2R-CE, RxR-CE, and R2R-PE benchmarks achieve new SOTA results, and real-robot tests across diverse environments demonstrate LatentPilot's superior understanding of environment-action dynamics in scene. Project page:https://abdd.top/latentpilot/
  •  

Liquid Biopsies in HNSCC: Current Landscape and Emerging Opportunities in the Era of HPV Stratification

Int J Mol Sci. 2026 Mar 20;27(6):2847. doi: 10.3390/ijms27062847.

ABSTRACT

Head and neck squamous cell carcinoma (HNSCC) is biologically and clinically dichotomous according to HPV status, a distinction that fundamentally dictates the design, implementation, and interpretation of liquid biopsy strategies. Conventional anatomical imaging lacks sufficient sensitivity for minimal residual disease (MRD) detection, contributing significantly to treatment failure and suboptimal clinical outcomes. This review provides a critical, evidence-based synthesis of the three principal circulating analytes, circulating tumor DNA (ctDNA), exosomes, and circulating tumor cells (CTCs), and their evolving roles in real-time, non-invasive molecular monitoring. Critically, the clinical readiness of these analytes differs substantially: while ctDNA, particularly HPV-related ctDNA, is approaching clinical validation for MRD detection and recurrence surveillance in HPV-positive HNSCC, exosomes and CTCs remain investigational tools hindered by ongoing technical challenges including lack of standardized assays, limited reproducibility across platforms, and insufficient prospective validation. We review how the presence of a clonal, virally derived DNA target in HPV-positive HNSCC contrasts with the heterogeneous somatic mutational landscape of HPV-negative tumors, necessitating divergent analytical platforms and yielding distinct clinical utility profiles for MRD detection and recurrence surveillance. We further outline a pragmatic translational pathway focused on assay standardization, particularly for exosomes and CTCs where this foundational work is most urgently needed, integration of complementary multimodal liquid biopsy approaches, and rigorously designed prospective interventional clinical trials to establish clinical utility. Collectively, these efforts aim to transition HNSCC management from reactive, anatomy-based surveillance to proactive, molecularly guided precision oncology, with the potential to improve therapeutic decision-making and patient outcomes.

PMID:41898706 | PMC:PMC13027142 | DOI:10.3390/ijms27062847

  •  
❌